iShares U.S. Medical Devices ETF (IHI) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.20: the stock has moved about 20% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnsweriShares U.S. Medical Devices ETF (IHI) trades at $50.45. The iShares U.S. Medical Devices ETF (IHI) aims to mirror the investment results of an index focused on U.S. equities within the medical devices sector. Sector: Financials.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for IHI: IHI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
iShares U.S. Medical Devices ETF (IHI) Financial Services Profile
iShares U.S. Medical Devices ETF (IHI) offers investors focused exposure to U.S. companies in the medical device sector, tracking a specialized index. With a $3.65 billion market cap and a beta of 1.20, IHI provides targeted access to the growth and innovation within the medical technology market, excluding dividend payouts.
What Is the Investment Thesis for IHI?
The iShares U.S. Medical Devices ETF (IHI) presents a focused investment opportunity in the U.S. medical device sector. With a beta of 1.20, IHI exhibits moderate volatility relative to the broader market. The fund's value is intrinsically tied to the growth and innovation within the medical device industry. Key catalysts include technological advancements in medical devices, increasing demand for healthcare services due to an aging population, and favorable regulatory environments. However, potential risks include regulatory hurdles, product liability concerns, and competitive pressures within the industry. Investors may want to evaluate these factors when evaluating IHI's potential for long-term growth. The absence of dividend payouts may deter income-focused investors.
Based on FMP financials and quantitative analysis
IHI Key Highlights
IHI has a market capitalization of $3.65 billion, indicating its significant presence in the asset management sector.
- The ETF's beta of 1.20 suggests it is slightly more volatile than the overall market.
- IHI offers focused exposure to the U.S. medical devices sector, allowing investors to target this specific industry.
- The fund tracks an index composed of U.S. equities in the medical devices sector, providing diversified exposure within the industry.
- IHI does not distribute dividends, which may be a consideration for income-seeking investors.
Who Are IHI's Competitors?
IHI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CGXU Capital Group International Focus Equity ETF | $34.71 | +1.46% | $6.40B | — |
| DXJ WisdomTree Japan Hedged Equity Fund | $182.03 | +1.28% | $7.41B | — |
| EAGG iShares ESG Aware U.S. Aggregate Bond ETF | $45.12 | -0.18% | $4.75B | — |
| IFRA iShares U.S. Infrastructure ETF | $56.19 | +1.19% | $4.25B | — |
| IYF iShares U.S. Financials ETF | $126.07 | +0.03% | $4.15B | — |
| BLK BlackRock, Inc. | $1059.63 | -0.44% | $164B | 51 5-pillar |
| BX Blackstone Inc. | $111.74 | -0.45% | $135B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | -0.23% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IHI's Key Strengths?
Targeted exposure to the U.S. medical devices sector.
- Diversified portfolio of companies within the industry.
- Low expense ratio compared to actively managed funds.
- Intraday liquidity and transparency.
What Are IHI's Weaknesses?
Lack of dividend payouts may deter income-seeking investors.
- Performance is dependent on the overall health of the medical devices sector.
- Beta of 1.20 indicates slightly higher volatility than the market.
- Susceptible to regulatory changes and industry-specific risks.
What Are the Key Risks for IHI?
Regulatory hurdles and product approval delays, impacting the commercialization of new medical devices.
- Product liability concerns and litigation risks, potentially leading to financial losses.
- Competitive pressures within the medical devices industry, impacting market share and profitability.
- Economic downturns and reduced healthcare spending, potentially affecting demand for medical devices.
- Dependence on the performance of the U.S. medical devices sector, making it vulnerable to industry-specific risks.
What Are IHI's Competitive Advantages?
- Diversification: IHI offers exposure to a wide range of companies within the medical devices sector, reducing the risk associated with investing in individual stocks.
- Low Expense Ratio: As an ETF, IHI typically has a lower expense ratio compared to actively managed funds, making it a cost-effective investment option.
- Liquidity: IHI is traded on major stock exchanges, providing investors with intraday liquidity and the ability to buy or sell shares easily.
What Does IHI Do?
The iShares U.S. Medical Devices ETF (IHI) is designed to provide investors with exposure to U.S. companies that operate within the medical devices sector. As an exchange-traded fund (ETF), IHI's primary objective is to closely track the investment results of an underlying index composed of U.S. equities specifically classified within the medical devices industry. This allows investors to gain targeted exposure to this particular segment of the broader healthcare market without needing to purchase individual stocks. The ETF's holdings include companies involved in the research, development, manufacturing, and distribution of medical devices, ranging from surgical instruments and diagnostic equipment to prosthetics and cardiovascular devices. By investing in IHI, investors gain access to a diversified portfolio of companies that are at the forefront of medical technology innovation. The fund rebalances its holdings periodically to ensure it continues to accurately reflect the composition of its underlying index. IHI's structure as an ETF offers several benefits, including intraday liquidity, transparency, and relatively low expense ratios compared to actively managed funds. It is designed to be a cost-effective way for investors to participate in the potential growth of the U.S. medical devices sector. The fund does not distribute dividends, which may be a consideration for income-seeking investors.
What Products and Services Does IHI Offer?
- Tracks the investment results of an index composed of U.S. equities in the medical devices sector.
- Provides investors with targeted exposure to the medical devices industry.
- Offers a diversified portfolio of companies involved in the research, development, manufacturing, and distribution of medical devices.
- Rebalances its holdings periodically to maintain alignment with its underlying index.
- Operates as an exchange-traded fund (ETF), providing intraday liquidity and transparency.
- Offers a cost-effective way for investors to participate in the potential growth of the U.S. medical devices sector.
- Does not distribute dividends, focusing on capital appreciation.
How Does IHI Make Money?
- IHI generates revenue through management fees charged to investors for managing the ETF.
- The fund's performance is directly tied to the performance of the U.S. medical devices sector.
- IHI aims to replicate the returns of its underlying index, providing investors with passive exposure to the industry.
What Industry Does IHI Operate In?
The iShares U.S. Medical Devices ETF (IHI) operates within the asset management industry, specifically focusing on the medical devices sector. This sector is characterized by continuous innovation, driven by technological advancements and increasing healthcare demands. The competitive landscape includes both established medical device manufacturers and emerging technology companies. IHI provides a vehicle for investors to participate in the growth of this sector through a diversified portfolio of U.S. equities. The ETF's performance is closely tied to the overall health and growth prospects of the medical device industry.
Who Are IHI's Key Customers?
- Individual investors seeking targeted exposure to the medical devices sector.
- Institutional investors looking for a cost-effective way to diversify their portfolios.
- Financial advisors seeking to provide their clients with access to the medical devices industry.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 41 snapshots
| 2026-08-23 | 44 |
| 2026-08-31 | 44 |
| 2026-09-08 | 44 |
| 2026-09-16 | 44 |
| 2026-09-24 | 44 |
| 2026-10-04 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved -6.4%.
Insider Activity
12 transactions · 0 purchases, 0 sales, 12 other transactions · 4 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
IHI Financials
Bull Case vs Bear Case
Bull Case
- Targeted exposure to the U.S. medical devices sector.
- Diversified portfolio of companies within the industry.
- Low expense ratio compared to actively managed funds.
- Intraday liquidity and transparency.
Bear Case
- Lack of dividend payouts may deter income-seeking investors.
- Performance is dependent on the overall health of the medical devices sector.
- Beta of 1.20 indicates slightly higher volatility than the market.
- Susceptible to regulatory changes and industry-specific risks.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
IHI Latest News
-
IHI Appoints Dr. Amar Shah as Chief Scientific Officer
businesswire.com · Sep 23, 2026
-
NewEdge Advisors LLC Raises Stock Position in iShares U.S. Medical Devices ETF $IHI
defenseworld.net · Sep 16, 2026
-
Baird Financial Group Inc. Purchases 43,629 Shares of iShares U.S. Medical Devices ETF $IHI
defenseworld.net · Sep 15, 2026
-
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
zacks.com · Sep 2, 2026
IHI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for IHI.
Price Targets
Wall Street price target analysis for IHI.
IHI MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for IHI; grades run from A+ (80-100) to F (below 30).
Latest News
IHI Appoints Dr. Amar Shah as Chief Scientific Officer
NewEdge Advisors LLC Raises Stock Position in iShares U.S. Medical Devices ETF $IHI
Baird Financial Group Inc. Purchases 43,629 Shares of iShares U.S. Medical Devices ETF $IHI
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
IHI Financials Stock FAQ
What does iShares U.S. Medical Devices ETF do?
The iShares U.S. Medical Devices ETF (IHI) is designed to track the investment results of an index composed of U.S. equities in the medical devices sector.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial goals.